Skip to main content

Table 1 Characteristics of patients with Stage IV kidney cancer, stratified by treatment group

From: Determinants of treatment in patients with stage IV renal cell carcinoma

 

All Patientsa

Patients surviving ≥ 6 months

 

No treatment

Surgery only

ST only

Surgery + ST

 

No treatment

Surgery only

ST only

Surgery + ST

 

Variable

(n = 486)

(n = 139)

(n = 214)

(n = 110)

P-value

(n = 237)

(n = 146)

(n = 164)

(n = 71)

P-value

Age at diagnosis

   

< 0.001

    

< 0.001

Mean (SD)

78.7 (7.43)

73.0 (5.39)

75.3 (5.67)

72.2 (5.26)

 

77.6 (7.39)

73.5 (5.31)

75.5 (5.6)

72.2 (5.19)

 

Sex

    

0.017

    

0.121

Male

238 (49.0%)

70 (50.4%)

120 (56.1%)

71 (64.5%)

 

59 (49.6%)

50 (48.5%)

74 (56.9%)

60 (63.2%)

 

Female

248 (51.0%)

69 (49.6%)

94 (43.9%)

39 (35.5%)

 

60 (50.4%)

53 (51.5%)

56 (43.1%)

35 (36.8%)

 

Race

    

0.19

    

0.222

White

388 (79.8%)

119 (85.6%)

163 (76.2%)

89 (80.9%)

 

95 (79.8%)

89 (86.4%)

98 (75.4%)

76 (80%)

 

Other

98 (20.2%)

20 (14.4%)

51 (23.8%)

21 (19.1%)

 

24 (20.2%)

14 (13.6%)

32 (24.6%)

19 (20%)

 

Urban/rural code

   

0.424

    

0.119

Big metro

232 (47.7%)

61 (43.9%)

98 (45.8%)

62 (56.4%)

 

58 (48.7%)

46 (44.7%)

53 (40.8%)

54 (56.8%)

 

Metro/urban

184 (37.9%)

53 (38.1%)

88 (41.1%)

35 (31.8%)

 

n/a

n/a

n/a

n/a

 

Less urban/rural

70 (14.4%)

25 (18.0%)

28 (13.1%)

13 (11.8%)

 

n/a

n/a

n/a

n/a

 

Other

n/a

n/a

n/a

n/a

 

61 (51.3%)

57 (55.3%)

77 (59.2%)

41 (43.2%)

 

Marital status

   

< 0.001

    

< 0.001

Unmarried

304 (62.6%)

69 (49.6%)

103 (48.1%)

33 (30.0%)

 

65 (54.6%)

51 (49.5%)

67 (51.5%)

26 (27.4%)

 

Married

182 (37.4%)

70 (50.4%)

111 (51.9%)

77 (70.0%)

 

54 (45.4%)

52 (50.5%)

63 (48.5%)

69 (72.6%)

 

Charlson comorbidity index

  

< 0.001

    

0.056

Mean (SD)

1.5 (1.76)

0.9 (1.31)

1.1 (1.34)

1.0 (1.48)

 

1.2 (1.58)

0.9 (1.4)

1.2 (1.35)

1.0 (1.4)

 
  1. ST systemic therapy
  2. aSubgroup for the landmark analysis at 6 months (n = 447): No treatment (n = 119); Surgery only (n = 103); ST only (n = 130); Surgery + ST (n = 95)